Retour
56
83
76
55
Fourchette du Jour
6,28 €
6,51 €
Fourchette 52 Semaines
5,60 €
17,43 €
Volume
1 384 671
Moyenne 50J / 200J
7,16 €
/
10,71 €
Clôture Précédente
6,25 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 3,1 | 0,4 |
| P/B | 1,3 | 2,9 |
| ROE % | 66,6 | 3,8 |
| Net Margin % | 52,3 | 3,9 |
| Rev Growth 5Y % | 535,7 | 10,0 |
| D/E | 0,4 | 0,2 |
Points Clés
Revenue grew 535,65% annually over 5 years — strong growth
ROE of 66,56% indicates high profitability
Net margin of 52,31% shows strong profitability
Debt/Equity of 0,37 — conservative balance sheet
Generating 172,79M in free cash flow
P/E of 3,11 — trading at a low valuation
Croissance
Revenue Growth (5Y)
535,65%
Revenue (1Y)617,03%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
66,56%
ROIC20,32%
Net Margin52,31%
Op. Margin48,17%
Sécurité
Debt / Equity
0,37
Current Ratio2,01
Interest Coverage53,97
Valorisation
P/E Ratio
3,11
P/B Ratio1,25
EV/EBITDA3,40
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 617,03% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 535,65% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 311,71M | Net Income (TTM) | 163,06M |
| ROE | 66,56% | ROA | 19,74% |
| Gross Margin | 88,46% | Operating Margin | 48,17% |
| Net Margin | 52,31% | Free Cash Flow (TTM) | 172,79M |
| ROIC | 20,32% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,37 | Current Ratio | 2,01 |
| Interest Coverage | 53,97 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 3,11 | P/B Ratio | 1,25 |
| P/S Ratio | 1,63 | PEG Ratio | -0,01 |
| EV/EBITDA | 3,40 | Dividend Yield | 0,00% |
| Market Cap | 507,50M | Enterprise Value | 510,59M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 311,71M | 43,47M | 0,0 | 65 408,0 | 190 936,0 |
| Net Income | 163,06M | -17,93M | -46,34M | -29,70M | -28,21M |
| EPS (Diluted) | 2,04 | -0,30 | -0,91 | -0,74 | -0,75 |
| Gross Profit | 275,75M | 40,28M | -205 562,0 | 61 674,0 | 41 998,0 |
| Operating Income | 150,14M | -22,36M | -48,96M | -30,62M | -29,44M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 826,14M | 118,85M | 82,06M | 62,04M | 68,95M |
| Total Liabilities | 420,84M | 34,19M | 11,92M | 6,98M | 6,15M |
| Shareholders' Equity | 405,31M | 84,66M | 70,14M | 55,06M | 62,80M |
| Total Debt | 148,91M | 517 013,0 | 667 632,0 | 802 433,0 | 923 801,0 |
| Cash & Equivalents | 145,83M | 40,65M | 43,64M | 43,37M | 53,32M |
| Current Assets | 350,47M | 114,58M | 79,45M | 59,55M | 66,47M |
| Current Liabilities | 174,27M | 33,84M | 11,40M | 6,31M | 5,35M |
Scores de Stratégies
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#281 of 1024
Custom
Capital Light Compounder
#4 of 213
#36 of 658
#23 of 195
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Capital Light Compounder
Mar 24, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026
Entré
Value Investing (Warren Buffett)
Mar 24, 2026